Eicosanoids are involved in the permeability changes but not the pulmonary hypertension after systemic activation of complement.

Morganroth, M L

Eicosanoids are involved in the permeability changes but not the pulmonary hypertension after systemic activation of complement. [electronic resource] - Laboratory investigation; a journal of technical methods and pathology Mar 1988 - 316-23 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0023-6837


6-Ketoprostaglandin F1 alpha--metabolism
Animals
Blood Pressure
Capillary Permeability
Chromatography, High Pressure Liquid
Complement Activation
Cyclooxygenase Inhibitors
Elapid Venoms--pharmacology
Hypertension, Pulmonary--etiology
Indomethacin--pharmacology
Leukotriene B4--metabolism
Lipoxygenase Inhibitors
Lung--drug effects
Male
Naphthols--pharmacology
Organ Culture Techniques
Rats
SRS-A--metabolism
Thromboxane B2--metabolism